{"id":"neoadjuvant-chemotherapyi","safety":{"commonSideEffects":[{"rate":"30-50%","effect":"Nausea"},{"rate":"20-40%","effect":"Vomiting"},{"rate":"20-40%","effect":"Fatigue"},{"rate":"10-30%","effect":"Hair loss"},{"rate":"10-20%","effect":"Diarrhea"},{"rate":"5-15%","effect":"Anemia"},{"rate":"5-15%","effect":"Infection"},{"rate":"5-15%","effect":"Neutropenia"},{"rate":"5-10%","effect":"Thrombocytopenia"},{"rate":"5-10%","effect":"Anorexia"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"This approach allows for more effective surgery and potentially reduces the risk of cancer recurrence. The specific chemotherapy agents used may vary depending on the type and stage of cancer.","oneSentence":"Neoadjuvant chemotherapy involves administering chemotherapy before the main treatment to reduce tumor size and make it easier to remove.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:22:59.104Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Breast cancer"},{"name":"Colorectal cancer"},{"name":"Esophageal cancer"},{"name":"Gastric cancer"},{"name":"Head and neck cancer"},{"name":"Lung cancer"},{"name":"Pancreatic cancer"},{"name":"Soft tissue sarcoma"},{"name":"Stomach cancer"},{"name":"Thymus cancer"}]},"trialDetails":[{"nctId":"NCT05194878","phase":"PHASE3","title":"Neoadjuvant FOLFOXIRI Versus Immediate Surgery for Stage II and III Colon Cancers","status":"RECRUITING","sponsor":"Sun Yat-sen University","startDate":"2021-12-01","conditions":"Colon Cancer Stage II, Colon Cancer Stage III","enrollment":840}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["mFOLFOXIR"],"phase":"phase_3","status":"active","brandName":"neoadjuvant chemotherapyI","genericName":"neoadjuvant chemotherapyI","companyName":"Sun Yat-sen University","companyId":"sun-yat-sen-university","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Neoadjuvant chemotherapy involves administering chemotherapy before the main treatment to reduce tumor size and make it easier to remove. Used for Breast cancer, Colorectal cancer, Esophageal cancer.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}